• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; AFX2 BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; AFX2 BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-110/I20-30
Device Problems Material Puncture/Hole (1504); Product Quality Problem (1506); Use of Device Problem (1670); Material Integrity Problem (2978); Unintended Movement (3026)
Patient Problem Failure of Implant (1924)
Event Date 01/29/2019
Event Type  Injury  
Manufacturer Narrative
The device will not be returned for evaluation.A follow-up report will be submitted upon completion of investigation.
 
Event Description
The patient was initially treated with the afx2 abdominal aortic aneurysm stent.Approximately three (3) years post initial implant the patient was found to have a possible type iiib endoleak after review of the patients follow-up ct scan.The physician has scheduled an angiogram as well as a secondary procedure for a future date to address the findings.
 
Manufacturer Narrative
At the completion of the clinical evaluation and based on the information received, there was substantial evidence to support the following reported events: type iiib endoleak of the bifurcated device and secondary endovascular procedure.The clinical assessment also determined that there was evidence to reasonably suggest a type iiia endoleak mid-aortic occurred that was not included in the event as reported; this endoleak was discovered during the review of the 33-month post-implant ct scan.The event is most likely user-related due to the off-label use of the infrarenal extension in the left common iliac artery (oversized stent in the left leg of the bifurcated device).A contributing factor to the type iiie endoleak was most likely the poor wall-to-wall apposition observed on 33-month post-implant ct scan.Procedure-related harms for this complaint could not be determined.The patient was reportedly doing well post secondary endovascular repair.The manufacturing lot review confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.A root cause investigation was carried out for all afx complaints having an identified failure mode of a type iiib endoleak.Endologix implemented the following corrective actions with the intent of reducing type iiib endoleak events; 1.Upgraded graft material (i.E.Duraply) and 2.Updates to the ifu and additional physician training.The change to duraply graft material and the ifu changes were put in place (b)(4) 2014.Correction: (b)(4).
 
Event Description
Additional information received confirming that the physician elected to treat the patient by relining with an additional bifurcated afx2 and suprarenal afx devices on (b)(6) 2019.During the procedure, no endoleak was evident but it was noted that the bifurcated device had dropped into the aneurysm sac.The patient was reportedly doing well post re-intervention.In addition, clinical assessment confirmed that a type iiia (aortic) endoleak was present at the time of the reported event.Clinical also determined the off-label use of the infrarenal (proximal extension) afx device in the left common iliac artery (lcia) at the time of the initial implant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
AFX2 BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key8376416
MDR Text Key137361156
Report Number2031527-2019-00108
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014542
UDI-Public(01)00818009014542(17)170224
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 01/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/24/2017
Device Model NumberBEA28-110/I20-30
Device Lot Number1355042-005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/31/2019
Initial Date FDA Received02/27/2019
Supplement Dates Manufacturer Received01/31/2019
Supplement Dates FDA Received05/03/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/09/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0007-2019
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age79 YR
-
-